0001213900-24-041832.txt : 20240510 0001213900-24-041832.hdr.sgml : 20240510 20240510172009 ACCESSION NUMBER: 0001213900-24-041832 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 EFFECTIVENESS DATE: 20240510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAINZ BIOMED N.V. CENTRAL INDEX KEY: 0001874252 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-486514 FILM NUMBER: 24936058 BUSINESS ADDRESS: STREET 1: ROBERT KOCH STRASSE 50 CITY: MAINZ STATE: 2M ZIP: 55129 BUSINESS PHONE: 49 6131 5542860 MAIL ADDRESS: STREET 1: ROBERT KOCH STRASSE 50 CITY: MAINZ STATE: 2M ZIP: 55129 FORMER COMPANY: FORMER CONFORMED NAME: Mainz Biomed B.V. DATE OF NAME CHANGE: 20210721 D/A 1 primary_doc.xml X0708 D/A LIVE 0001874252 MAINZ BIOMED N.V. ROBERT KOCH STRASSE 50 MAINZ 2M GERMANY 55129 +49-6131-55428-60 NETHERLANDS None Mainz Biomed B.V. Corporation true 2021 William Caragol Robert Koch Strasse 50 c/o Mainz Biomed N.V. Mainz 2M GERMANY 55129 Executive Officer Guido Baechler Robert Koch Strasse 50 c/o Mainz Biomed N.V. Mainz 2M GERMANY 55129 Executive Officer Director Moritz Eidens Robert Koch Strasse 50 c/o Mainz Biomed N.V. Mainz 2M GERMANY 55129 Executive Officer Director Heiner Dreismann Robert Koch Strasse 50 c/o Mainz Biomed N.V. Mainz 2M GERMANY 55129 Director Nicole Holden Robert Koch Strasse 50 c/o Mainz Biomed N.V. Mainz 2M GERMANY 55129 Director Hans Hekland Robert Koch Strasse 50 c/o Mainz Biomed N.V. Mainz 2M GERMANY 55129 Director Alberto Libanori Robert Koch Strasse 50 c/o Mainz Biomed N.V. Mainz 2M GERMANY 55129 Director Phillip Freese Robert Koch Strasse 50 c/o Mainz Biomed N.V. Mainz 2M GERMANY 55129 Executive Officer Darin Leigh Robert Koch Strasse 50 c/o Mainz Biomed N.V. Mainz 2M GERMANY 55129 Executive Officer Gregory Tibbits Robert Koch Strasse 50 c/o Mainz Biomed N.V. Mainz 2M GERMANY 55129 Director Biotechnology Decline to Disclose 06b true 0001213900-23-056204 2023-06-28 false true true true true false 0 50000000 14300000 35700000 Offering of $3,300,000 of ordinary shares under pre-paid advance agreement via promissory note convertible up to 4,166,667 shares at conversion price of $1.20 (subject to a reset date and floor) until four-month anniversary of the promissory note. false 1 0 0 0 true false MAINZ BIOMED N.V. /s/ William J. Caragol William J Caragol Chief Financial Officer 2024-05-10